Work

625 - Efficacy and safety of 1.5% ruxolitinib cream in patients with facial and/or neck atopic dermatitis: a randomized, double-blind, decentralized phase 2 study

Year: 2024

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: British Journal of Dermatology

DOI: 10.1093/bjd/ljae266.009

Authors: Zelma C Chiesa Fuxench, Zhihong Lai, YuTzu Kuo, Haq Nawaz, Jonathan Cotliar

Institutions: University of Pennsylvania, Incyte (United States)

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401435877

FWCI:

Cites:

Cited by:

Related to: 10